top of page
Search

Biden’s New Medicine Rules Have Pharmaceutical Companies Slow-Walking New Therapies

Pharmaceutical companies are delaying, or outright canceling, the development of new medicines following new drug rules signed into law by President Joe Biden, Bloomberg reported.


Recent Posts

See All

We Work For Health brings together national and local business leaders, labor, biopharma, patient advocacy, and other healthcare-related stakeholders to support policies and initiatives that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines. 

We Work For Health. © 2023 All Rights Reserved.

Privacy

Terms of Use

bottom of page